A study led by Som Nanjappa at the University of Illinois College of Veterinary Medicine identifies a cellular target that may improve efficacy in vaccines designed to protect immunocompromised individuals from potentially ...
Oct 27, 2018
0
5
The development of new drugs to fight a common fungal pathogen which kills half a million people globally each year is a step closer thanks to a University of Queensland-led study.
Jul 24, 2017
0
1
On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult ...
Oct 7, 2013
0
1
Hospital-acquired infections are a serious threat to patient lives, especially with the rise of antibiotic-resistant bacteria. One drug that may prove helpful in the fight against these infections is monophosphoryl Lipid ...
Jun 15, 2018
0
1
The pathogenic fungus Aspergillus fumigatus escapes elimination from surface cells of the human lung by binding to a human protein. In doing so, it is able to nest in so called phagosomes, confined areas in the lung cells, ...
Mar 8, 2023
0
6
Researchers at the University of Illinois College of Veterinary Medicine have demonstrated in a mouse model that a specific type of T cell, one of the body's potent immune defenses, produces cytokines that are necessary for ...
Oct 25, 2022
0
45
Australian scientists have shown that a specific gene determines the development and function of important cells that bridge the gap between our fast-acting 'innate', and slower-acting 'adaptive', immune systems.
May 4, 2015
0
14
The microbiological world is comprised of many organisms, including bacteria, viruses, and fungi. Though not generally regarded as pathogens by the greater public, fungi can cause an array of severe diseases, especially in ...
Nov 17, 2023
0
0
The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell therapy, to cut the risk of infection in patients with blood cancer following a myeloablative ...
Apr 24, 2023
0
0
The last drug designed to more effectively treat dangerous systemic fungal infections, most often affecting immunocompromised patients, was developed over 20 years ago. Now an interdisciplinary team of investigators from ...
Nov 2, 2021
0
48
